Author: Liu, Michael
Title: Nascent perspectives on COVID-19 treatments Cord-id: x6b6puw1 Document date: 2021_10_4
ID: x6b6puw1
Snippet: As of June 29th, 2021, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or COVID-19, has resulted in a global incidence of 181007816 cases, with corresponding mortality of 3927222 or a mortality rate of 2.2%. Global COVID-19 vaccination efforts have resulted in about 2.97 billion doses administered or approximately 19.4% of the global population. Despite vaccination and other preventative efforts, the ongoing mutation of the COVID-19 virus continues to cause signific
Document: As of June 29th, 2021, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or COVID-19, has resulted in a global incidence of 181007816 cases, with corresponding mortality of 3927222 or a mortality rate of 2.2%. Global COVID-19 vaccination efforts have resulted in about 2.97 billion doses administered or approximately 19.4% of the global population. Despite vaccination and other preventative efforts, the ongoing mutation of the COVID-19 virus continues to cause significant morbidity and mortality. Therefore, pharmacologic interventions remain essential in managing severe symptomatic presentation of COVID-19, which includes acute respiratory distress syndrome, severe cytokine storm, and septic shock. This article has reviewed several unique case studies published from August 2020 through June 2021 with the above perspectives.
Search related documents:
Co phrase search for related documents- action mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- action mechanism and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- action mechanism and adaptor protein: 1
- action mechanism and load reduction: 1, 2
- action mechanism and loading dose: 1, 2
- action mechanism and long term exposure: 1, 2
- action mechanism and low incidence: 1
- action mechanism and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- active rheumatoid arthritis and acute respiratory syndrome: 1, 2
- active rheumatoid arthritis and acute respiratory syndrome coronavirus: 1
- activity limitation and acute respiratory syndrome: 1, 2
- activity limitation and acute respiratory syndrome coronavirus: 1
- actual risk and acute respiratory syndrome: 1, 2, 3, 4, 5
- actual risk and acute respiratory syndrome coronavirus: 1, 2
Co phrase search for related documents, hyperlinks ordered by date